Immune Support Supplements: A Review of Nutrient Synergy and Resilience

The idea that the innate immune system — the rapid, non-specific first-responder arm that comprises macrophages, neutrophils, NK cells, and the complement cascade — has no memory was one of the foundational assumptions of immunology for most of the twentieth century. Memory was considered exclusively the province of the adaptive immune system: the antigen-specific B and T lymphocytes that generate long-lived memory cells encoding the precise molecular signature of a previous pathogen encounter. The innate system, by contrast, was understood to respond with fixed, genetically encoded patterns — the same Toll-like receptor activations, the same cytokine responses, the same phagocytic machinery — regardless of prior exposure history. In 2011, and more comprehensively in a landmark 2016 paper in Science, Mihai Netea and colleagues at Radboud University Medical Centre published evidence that overturned this assumption: monocytes and macrophages trained with β-glucan (a fungal cell wall polysaccharide) or BCG vaccine showed enhanced inflammatory cytokine responses to subsequent, entirely unrelated pathogen stimuli — responses that persisted for months after the initial training stimulus was cleared, and that were not mediated by B or T cells. The mechanism, the group demonstrated, was epigenetic: histone H3K4me3 and H3K27ac activating marks were durably deposited at the promoter and enhancer regions of innate inflammatory gene loci during the training event, lowering the transcriptional threshold for these genes in the reprogrammed macrophage. Innate immune memory — trained immunity — was real, mechanistically distinct from adaptive memory, and nutritionally addressable through the same methyl-donor co-factors that any epigenetic modification programme requires.

This discovery establishes the conceptual framework for this article's approach to immune-support supplement nutrient synergy: the immune system is not a static machine whose performance is determined by a fixed genetic programme. It is a dynamically regulated biological system whose responsiveness, resolution capacity, and tissue tolerance calibration are continuously shaped by epigenetic programming events — events whose molecular substrate includes the methyl donors, antioxidants, and trace mineral co-factors that nutritional supplementation can meaningfully influence. The five immune dimensions covered in this article — trained immunity, NLRP3 inflammasome regulation, NK cell cytotoxicity, specialised pro-resolving mediator biology, and the gut-immune axis — each represent a mechanistically distinct, clinically consequential aspect of immune resilience that the nutrient synergy model addresses more effectively than any single-ingredient approach. Each maps to specific Zenutri TGA-listed formulations through documented molecular pathways rather than through generic "immune support" claims.

Trained Immunity: Epigenetic Reprogramming and Innate Immune Memory

The epigenetic mechanism of trained immunity is not an exotic phenomenon limited to BCG vaccination or β-glucan administration in research settings — it is a continuously operating biological programme by which the innate immune system updates its responsiveness based on the cumulative history of exposures to pathogens and damage signals the body has encountered. Every significant innate immune activation event deposits some degree of histone modification at inflammatory gene loci in the responding monocytes and macrophages that survive — modifications that alter the chromatin accessibility of these loci and shift the transcriptional response threshold upward (in the case of immune tolerance, driven by H3K27me3 silencing marks) or downward (in trained immunity, driven by H3K4me3 and H3K27ac activating marks). The nutritional substrate for both types of epigenetic modification is the same: SAM (S-adenosylmethionine) provides the methyl group for H3K4me3 deposition by KMT2 methyltransferase enzymes; histone acetylation at H3K27ac requires acetyl-CoA, whose cytoplasmic concentration reflects mitochondrial metabolic output; and zinc serves as the structural co-factor for the zinc-finger domains of the bromodomain and extra-terminal domain (BET) proteins that read H3K27ac marks and recruit the transcriptional machinery to accessible loci. Without adequate SAM (from the MTHFR folate cycle), without adequate mitochondrial acetyl-CoA flux, and without adequate zinc for BET reader function, the epigenetic writing and reading of innate immune memory marks is substrate-limited — constraining the immune system's capacity to calibrate its responsiveness based on experience.

The metabolic intersection of trained immunity with the broader methylation and mitochondrial biology covered in the longevity article is not coincidental. The Netea group demonstrated in their mechanistic dissection of trained immunity that the metabolic shift from oxidative phosphorylation to aerobic glycolysis (the Warburg-like transition of activated macrophages) is not merely an energy production adaptation — it is the metabolic signal that drives the epigenetic reprogramming. The elevated citrate produced by this shifted metabolism is exported from the mitochondria to the cytoplasm, where it is cleaved by ATP citrate lyase to produce acetyl-CoA — the substrate for H3K27ac histone acetylation at trained immunity loci. Coenzyme Q10 and NAD+, which determine the efficiency and output of the mitochondrial TCA cycle and ETC, therefore influence the availability of metabolic substrates for the epigenetic histone acetylation events that trained immunity requires. The implication is that the same formulations supporting mitochondrial integrity for energy and longevity — Reversa NR (AUST L 520794) for NAD+ and UbiQ Forte (AUST L 520795) for CoQ10 — also support the metabolic substrate supply for innate immune epigenetic reprogramming, through a mechanism entirely distinct from their direct antioxidant or energy roles. Take the free Zenutri health quiz to understand which of these mechanisms is most relevant to your current immune and energy health priorities.

Resolvins and the Epigenetic Programme of Immune Resolution

The epigenetic dimension of immune regulation extends beyond the activation phase covered by trained immunity into the resolution phase — the active biological programme that terminates appropriate inflammatory responses and restores tissue homeostasis. Resolution is not passive; it is driven by changes in macrophage gene expression that produce an M2-like anti-inflammatory phenotype through the same histone modification mechanisms that underlie activation in trained immunity. The Vitamin D receptor (VDR) in macrophages, activated by calcitriol, directly regulates histone deacetylase (HDAC) activity and promotes the chromatin accessibility of anti-inflammatory gene loci — providing a genomic mechanism through which Vitamin D3 sufficiency (Osteo+Core AUST L 520792) supports not just cathelicidin production and T cell balance but the epigenetic programme of inflammatory resolution in tissue macrophages.

The NLRP3 Inflammasome, IL-1β, Pyroptosis, and the Inflammageing Hub

The NLRP3 inflammasome is one of several cytoplasmic pattern recognition receptor complexes in the NOD-like receptor (NLR) family, but it has emerged as the most clinically significant because of its remarkably broad activation spectrum — it can be triggered by bacterial toxins, viral RNA intermediates, extracellular ATP (a DAMP released by necrotic cells), monosodium urate crystals (the mechanism of gout flares), cholesterol crystals (a driver of atherosclerotic plaque inflammation), mitochondrial ROS, and saturated fatty acid metabolites. This broad activation profile makes NLRP3 the molecular hub that translates metabolic danger signals — the cholesterol crystals of dyslipidaemia, the uric acid of hyperuricaemia, the mitochondrial ROS of energy metabolism dysfunction — into the cytokine output that drives the chronic, low-grade systemic inflammation of inflammageing. Understanding NLRP3 explains why metabolic health and immune health are not separate categories: they are connected by this single inflammasome sensor.

NLRP3 activation requires two sequential signals. Signal 1 (priming): a TLR or cytokine receptor stimulus — typically from microbial PAMPs or TNF-α — activates NF-κB, which drives transcription of NLRP3 protein, pro-IL-1β, and pro-IL-18 (these are synthesised in inactive forms that require caspase-1 cleavage for secretion). Signal 2 (activation): a DAMP or metabolic danger signal activates the assembled inflammasome complex — NLRP3 oligomerises and recruits the ASC adaptor protein, which oligomerises into a single large structure called the ASC speck visible by fluorescence microscopy as a bright punctum in the activated macrophage. The ASC speck recruits and activates procaspase-1 autoproteolytically; active caspase-1 cleaves pro-IL-1β to IL-1β and pro-IL-18 to IL-18, and simultaneously cleaves gasdermin D — the pore-forming protein whose N-terminal fragment inserts into the plasma membrane to create the gasdermin pores through which IL-1β is secreted and through which the osmotic imbalance that drives pyroptotic cell death proceeds. Pyroptosis — NLRP3-driven, inflammatory cell death releasing the cell's full intracellular content, including all accumulated DAMPs and inflammatory mediators — is the mechanism by which a single excessively activated macrophage amplifies the local inflammatory signal into a broader tissue crisis.

Magnesium and Curcumin as NLRP3 Modulators

Two nutrients within the Zenutri range have specific, mechanistically documented effects on NLRP3 activation that are distinct from their primary indications. Magnesium (as amino acid chelate in MagLipo Core, AUST L 520793) directly antagonises the P2X7 receptor — the purinergic receptor that extracellular ATP activates to provide Signal 2 for NLRP3 — through competitive calcium channel blockade: Mg²⁺ and Ca²⁺ compete for the same P2X7 channel, and adequate intracellular magnesium raises the ATP concentration threshold required for P2X7 activation. This means that magnesium sufficiency effectively raises the DAMP signal threshold required to trigger NLRP3 activation in macrophages — a mechanism that contributes to magnesium deficiency's well-documented association with elevated systemic inflammation and C-reactive protein in population studies, and that is mechanistically distinct from magnesium's more widely cited NMDA receptor and ATP synthase co-factor roles. Curcumin (CurcuNova, AUST L 520796) addresses both NLRP3 signals: its NF-κB inhibition (via IKKβ kinase suppression, preventing IκB phosphorylation and NF-κB nuclear translocation) directly suppresses Signal 1 NLRP3 priming transcription; and multiple in vitro studies have demonstrated curcumin's direct interaction with the NLRP3 protein that inhibits ASC speck assembly — the Signal 2 step. The piperine-enhanced bioavailability of CurcuNova's curcumin (Shoba 1998, Planta Medica — 2,000% bioavailability enhancement with 20mg piperine) is directly relevant to whether the NLRP3-inhibitory curcumin concentrations demonstrated in cell-based research are achievable in human tissue — a threshold that standard curcumin without piperine typically fails to reach. Safety note: Piperine in CurcuNova inhibits CYP3A4; antidepressant medication users must discuss with their GP before initiating. Warfarin users require GP review. Pregnancy — pause CurcuNova (see maternity safety article).

NK Cell Cytotoxicity: NKG2D, Perforin-Granzyme, and Selenium Support

Natural Killer cells occupy a unique strategic position in the immune architecture that is entirely distinct from the antibody-mediated and T cell-mediated responses that receive the most attention in conventional immune health discussions. While CD8+ cytotoxic T cells require prior antigen exposure and MHC class I-presented peptide recognition to engage a target — a process that takes days to weeks for a primary response — NK cells can engage and destroy targets they have never previously encountered, within hours of first contact, using a recognition system based not on specific antigens but on the ratio of activating to inhibitory signals detected on the target cell surface. The activating receptors that dominate this recognition include NKG2D (recognising MICA, MICB, and ULBP stress ligands upregulated on virally infected and tumour cells) and DNAM-1 (recognising PVR/CD155 and nectin-2 on transformed cells). The inhibitory receptors — predominantly KIR family receptors and the NKG2A/CD94 heterodimer — recognise normal MHC class I molecules on healthy cells, generating the inhibitory signal that prevents NK killing of non-stressed tissues. The net outcome: virally infected cells that downregulate MHC class I to escape CD8+ T cell surveillance simultaneously remove the inhibitory signal from NK receptors and increase activating ligand display, making NK cells uniquely effective at precisely the targets that have evolved the most successful immune escape strategy against adaptive immunity.

When the activating signal threshold is exceeded, the NK cell forms a directed immunological synapse with the target and delivers its cytotoxic payload through two convergent mechanisms. Perforin — a calcium-dependent pore-forming protein stored in NK lytic granules — is exocytosed into the synaptic cleft and inserts into the target cell membrane, oligomerising to create pores of 5-20nm diameter through which the second payload — granzymes (serine proteases, principally Granzyme B) — enters the target cell and directly activates pro-caspase-3 and -8, initiating rapid apoptotic cell death. The directional specificity of this degranulation process — releasing lytic granule contents only into the synapse against the target rather than indiscriminately into the surrounding tissue — requires precise cytoskeletal polarisation and microtubule-organising centre (MTOC) reorientation toward the synapse, a process that is ATP-dependent and therefore influenced by the mitochondrial health of the NK cell itself. Selenium's role in NK cytotoxicity extends beyond the GPx selenoprotein protection of lytic granule contents during degranulation: selenoprotein P, the principal extracellular selenium transport protein, is essential for providing selenium to the thymic and bone marrow microenvironments where NK cell precursors develop and mature — creating a development-level dependency on selenium sufficiency that is upstream of mature NK cell function. Immunaxis (AUST L 521494) provides selenomethionine at 100mcg and zinc glycinate at 20mg — selenium for GPx/selenoprotein P NK functional support, zinc for the IL-2 and IL-15 cytokine receptor signalling that drives NK cell expansion and activation. The combination addresses the NK cell system from development through degranulation in a single TGA-listed formulation.

Specialised Pro-Resolving Mediators: The Active Biology of Immune Resolution

Every effective immune response contains within itself the seeds of its own termination — not because inflammatory mediators are simply diluted or degraded over time, but because the inflammatory process itself generates the lipid precursors for a distinct class of molecules whose sole function is to actively terminate the response and restore tissue homeostasis. This resolution programme — discovered and characterised primarily by Charles Serhan's group at Harvard Medical School across two decades of research — is executed by specialised pro-resolving mediators (SPMs): a family of oxygenated lipid mediators derived from polyunsaturated fatty acids through lipoxygenase and cyclooxygenase enzymatic pathways that had been studied primarily for their pro-inflammatory eicosanoid products. The SPMs include lipoxins (LXA4 and LXB4, derived from arachidonic acid via sequential 15-LOX and 5-LOX reactions), resolvins (E-series RvE1, RvE2 from EPA via aspirin-modified COX-2 and 5-LOX; D-series RvD1, RvD2, RvD3 from DHA via 15-LOX and 5-LOX), protectins/neuroprotectins (PD1/NPD1 from DHA via 15-LOX), and maresins (from DHA via 12-LOX in macrophages). Each class engages specific G-protein-coupled receptors — LXA4 at ALX/FPR2, RvE1 at ChemR23, RvD1 and RvD2 at GPR18 and DRV1 — to programme specific pro-resolution cell responses.

The resolution programme driven by these receptors encompasses neutrophil apoptosis (counteracting the continued tissue damage from inflammatory neutrophil proteases and ROS once the pathogen is cleared), macrophage phenotype switching from M1 inflammatory to M2 phagocytic/anti-inflammatory, efferocytosis (the engulfment and non-inflammatory clearance of apoptotic neutrophil debris by macrophages — a process that itself generates SPMs and amplifies the resolution signal), and restoration of vascular and epithelial barrier integrity through epithelial cell proliferation and collagen synthesis. This is why the same nutrients that support immune activation — Vitamin C for neutrophil function, zinc for macrophage activation, selenium for GPx NK cell function — also support immune resolution when provided in the context of a complete network antioxidant protocol: Vitamin C's prolyl hydroxylase co-factor role is essential for the collagen synthesis that completes the tissue restoration phase of resolution; mixed tocopherols provide the lipid-phase antioxidant environment that protects the DHA and EPA membrane phospholipids from oxidation before they can serve as SPM precursor substrates; and the 15-LOX enzyme that generates the initial SPM intermediates from DHA and EPA requires iron and selenium co-factor support for its peroxidase activity. An immune support protocol oriented toward both response capacity and resolution capacity — using C E B Optima (AUST L 521487) Vitamin C and mixed tocopherols alongside Immunaxis (AUST L 521494) selenium and zinc — addresses both phases of the immune cycle rather than only the inflammatory activation phase that most supplement discussions focus on. For a deeper review of the EPA/DHA omega-3 substrate availability dimension of the resolvin biosynthesis pathway, the zinc and immune resilience article covers the competing substrate dynamics of AA versus EPA in eicosanoid production.

The Gut-Immune Axis: Peyer's Patches, SCFA Tregs, and Barrier Integrity

The gut is not simply the site of nutrient absorption that happens to have some immune cells nearby. It is, by cell number, the largest immune organ in the human body — housing approximately 70% of the body's immune cells in gut-associated lymphoid tissue (GALT) whose function determines the systemic immune calibration between tolerance (of commensal bacteria, dietary proteins, and self-antigens) and reactivity (against pathogens and genuinely dangerous antigens). The architectural centrepiece of this GALT immune sampling function is the Peyer's patch — raised lymphoid nodules in the small intestinal submucosa containing B cell follicles, T cell zones, and the specialised epithelial cells called M (microfold) cells that overlie them. M cells are morphologically and functionally distinct from the absorptive enterocytes that cover most of the intestinal villus surface: they have sparse surface microvilli (reducing the mucus layer that covers enterocytes), express specific transcytosis receptors for bacterial surfaces and dietary lectins, and actively endocytose luminal content — transporting intact bacteria, viruses, and particulate antigens across the epithelium to the dendritic cells and macrophages in the subepithelial dome beneath the Peyer's patch, where antigen presentation initiates adaptive immune responses including the IgA class-switching that generates the sIgA-secreting lamina propria plasma cells.

The SCFA-Treg connection is one of the most consequential gut-immune mechanisms for systemic immune calibration. Short-chain fatty acids — particularly butyrate, propionate, and acetate — are produced by the fermentation of dietary fibre by commensal Firmicutes and Bacteroidetes bacteria in the colon. Butyrate is the most immunologically active SCFA: it enters colonocytes and lamina propria cells where it inhibits histone deacetylase (HDAC) enzymes, increasing histone H3 and H4 acetylation at gene loci, including the FOXP3 transcription factor gene. FOXP3 is the master regulator of the regulatory T cell (Treg) lineage — its expression drives the differentiation of naive CD4+ T cells into immune-suppressive Tregs that produce IL-10 and TGF-β, suppressing excessive inflammatory responses and calibrating immune tolerance to the microbiome. This SCFA-HDAC-FOXP3-Treg axis is the molecular mechanism by which dietary fibre intake and microbiome diversity maintain systemic immune tolerance — and its impairment by antibiotics, fibre-deficient diets, and microbiome dysbiosis contributes to the elevated background inflammatory tone of modern Western populations. The same Vitamin D3/VDR signalling that supports cathelicidin production in the lung (the Martineau 2017 mechanism covered in the immune support article) also directly promotes FOXP3 Treg differentiation in the intestinal lamina propria through a VDR response element in the FOXP3 promoter — providing a second, intestinal-immune pathway through which Osteo+Core (AUST L 520792) D3 at 1,000 IU supports the tolerance/reactivity calibration that determines whether the immune system overreacts to environmental stimuli or maintains the resilient balance that genuine immune health represents.

Zinc and the Epithelial Barrier: The First Line Before Immunity Begins

Before any of the GALT immune architecture can engage a pathogen, that pathogen must first penetrate the epithelial barrier — the single-cell-layer interface between the gut lumen and the submucosal immune tissue. This barrier's integrity is maintained by tight junction proteins (occludin, claudin, zonula occludens ZO-1) whose assembly and maintenance require zinc as a co-factor for multiple kinases and transcription factors that regulate tight junction gene expression and protein phosphorylation. Zinc deficiency is well documented to increase intestinal permeability — elevating passage of bacterial products (particularly LPS) through the paracellular space that provides the NLRP3-priming Signal 1 stimulus that, when sustained by chronic permeability, drives the chronic low-grade inflammation of the "leaky gut" concept. The zinc glycinate in Immunaxis (AUST L 521494) therefore supports the gut-immune axis at two distinct sites simultaneously: epithelial tight junction integrity (preventing the LPS translocation that drives NLRP3 priming) and Peyer's patch IgA class-switch recombination efficiency (ensuring the sIgA production that provides immune exclusion of the pathogens that do reach the mucosal surface). This dual gut-immune barrier function — upstream physical barrier and downstream immunological barrier — makes zinc glycinate's role in gastrointestinal immune health mechanistically broader than its commonly discussed systemic immune functions alone.

The Zenutri Nutrient Synergy Immune Protocol

The five immune mechanisms reviewed in this article — trained immunity epigenetic co-factor support, NLRP3 inflammasome suppression, NK cell cytotoxicity selenoprotein support, SPM resolution programme antioxidant substrate protection, and gut-immune axis barrier and Treg support — together with the innate TLR zinc-finger signalling, GPx4 ferroptosis protection, and mucosal IgA biology covered in the natural immune support article, constitute a comprehensive molecular map of the nutritionally addressable dimensions of immune resilience. The Zenutri formulations that address these mechanisms are:

Immunaxis (AUST L 521494) — Zinc glycinate 20mg, Selenomethionine 100mcg, Vitamin A 900mcg RE.
Mechanisms: NK cell GPx selenoprotein degranulation protection; selenium selenoprotein P for NK developmental microenvironment; zinc BET reader H3K27ac trained immunity; zinc P2X7 potentiation and tight junction barrier; Vitamin A IgA class-switch recombination in Peyer's patches; zinc pIgR sIgA mucosal transport.

CurcuNova (AUST L 520796) — Curcumin 20:1, Resveratrol 150mg, activated B-complex, BioPerine 13.9mg (Shoba 1998 2,000% bioavailability).
Mechanisms: NF-κB Signal 1 NLRP3 priming suppression; ASC speck assembly inhibition Signal 2; CD38 inflammageing NAD+ drain reduction; SAM methylation co-factor (activated B-complex) for trained immunity H3K4me3 histone methyltransferase. Safety: CYP3A4 — antidepressant medication users must discuss with GP; warfarin — GP review; shellfish allergy — levomefolate glucosamine note; pregnancy PAUSE.

C E B Optima (AUST L 521487) — Vitamin C 250mg, Mixed tocopherols 70mg, Nicotinamide 125mg.
Mechanisms: Ascorbate aqueous-phase antioxidant protecting EPA/DHA SPM precursor phospholipids from oxidative degradation before 15-LOX can convert them to resolvin/protectin intermediates; collagen prolyl hydroxylase co-factor for SPM resolution-phase tissue restoration; lipid-phase tocopherol chain-breaking preventing membrane lipid peroxide accumulation that triggers NLRP3; network antioxidant tocopherol-ascorbate recycling.

MagLipo Core (AUST L 520793) — Mg amino acid chelate 55mg elemental, ALA 150mg.
Mechanisms: Mg²⁺ P2X7 receptor competitive antagonism raising NLRP3 Signal 2 ATP threshold; ALA Nrf2/ARE pathway upregulation of endogenous antioxidant enzymes (SOD, GPx, catalase) reducing mitochondrial ROS that constitutes a chronic NLRP3 Signal 2 in metabolically stressed tissue; Mg GABA sleep quality supporting deep-sleep immune trafficking.

Osteo+Core (AUST L 520792) — D3 1,000 IU, K2-MK7 180mcg.
Mechanisms: VDR-FOXP3 intestinal Treg induction (gut-immune tolerance); VDR-HDAC macrophage M2 resolution phenotype epigenetic support; VDR-cathelicidin mucosal barrier innate defence; D3 serotonin synthesis supporting the gut serotonin pool (approximately 90% of body serotonin is in gut enterochromaffin cells) that modulates intestinal motility and GALT immune sampling.

The most accessible starting point is the Zenutri Immune & Antioxidant Nutrient Bundle (Immunaxis + CurcuNova + C E B Optima, $57.50, save 23%) — the three-formulation protocol addressing NK cytotoxicity, NLRP3 priming and assembly, trained immunity co-factors, and SPM antioxidant substrate protection simultaneously. For the foundational two-formulation approach addressing zinc-selenium NK/barrier/sIgA and Vitamin C-tocopherol network antioxidant/SPM protection, the Immune Nutrient Support Bundle (Immunaxis + C E B Optima, $36) provides the most direct NK-cell-and-resolution entry point. Adding MagLipo Core and Osteo+Core completes the five-mechanism NLRP3 suppression and gut-immune axis support.

Timing: Immunaxis and C E B Optima with a fat-containing morning meal (Vitamin A fat-soluble absorption; zinc amino acid chelate well-tolerated with food). CurcuNova with the largest daily meal for maximum piperine-enhanced curcumin absorption. MagLipo Core in the evening 30-60 minutes before sleep for the combined NLRP3 and sleep-quality benefits. Osteo+Core in the morning. Return to the free Zenutri health quiz at 90 days to assess immune resilience outcomes — infection frequency, recovery speed, inflammatory marker trends — and adjust the protocol based on your updated health context.

Immune Resilience Requires Five Systems Working in Concert

The trained immunity epigenetic substrate, the NLRP3 inflammasome balance between appropriate activation and chronic dysregulation, the NK cell cytotoxic surveillance capacity, the specialised pro-resolving mediator programme that terminates inflammation as actively as it begins, and the gut-immune axis barrier and tolerance calibration that determines the entire system's background threshold — these five dimensions of immune biology collectively determine what genuine immune resilience looks like at the cellular and molecular level. Shared dependencies connect them: methyl-donor co-factors for epigenetic programming, selenium for selenoprotein function across both activation and resolution, zinc for barrier integrity, NK development, and IgA class switching, and the lipid antioxidant network that protects the polyunsaturated fatty acid substrates that the resolution programme requires. Nutrient synergy in this context is not a marketing phrase — it is the mechanistic description of why no single supplement can address all five dimensions, and why the combination of TGA-listed, bioavailability-optimised formulations at therapeutic doses produces immune support that transcends the sum of its parts.

Always read the label. Follow the directions for use. Supplements are not a substitute for a balanced diet. If symptoms persist, consult your healthcare professional.

Explore the Zenutri Immune & Antioxidant Nutrient Bundle — or take the free health quiz to receive a personalised immune resilience recommendation mapped to your age, health history, and the specific immune mechanisms most relevant to your biology.

Frequently Asked Questions

What is trained immunity and how can supplements support it?

Trained immunity is the epigenetic reprogramming of monocytes and macrophages — through histone H3K4me3 and H3K27ac activating marks deposited at innate inflammatory gene loci during a first pathogen encounter — that lowers response thresholds for subsequent challenges without antigen-specific adaptive memory (Netea 2016, Science). The nutritional co-factors required are SAM (methyl donor for H3K4me3 methyltransferase, from the MTHFR/B12/folate methylation cycle), acetyl-CoA (for H3K27ac acetylation, from TCA cycle citrate export), and zinc (for BET domain reader protein structural integrity). The activated B-complex in CurcuNova (AUST L 520796) and zinc glycinate in Immunaxis (AUST L 521494) provide the methylation and zinc co-factor support; Reversa NR (AUST L 520794) and UbiQ Forte (AUST L 520795) support the mitochondrial citrate-acetyl-CoA output through NAD+/CoQ10 mechanisms.

What is the NLRP3 inflammasome, and why does it matter for immune health?

The NLRP3 inflammasome (NLRP3 + ASC adaptor + procaspase-1) processes pro-IL-1β and pro-IL-18 into secreted inflammatory cytokines through caspase-1 cleavage — and drives pyroptotic cell death at maximum activation. It is the molecular hub connecting metabolic danger signals (cholesterol crystals, uric acid, extracellular ATP, mitochondrial ROS) to systemic inflammation and inflammageing. Magnesium (MagLipo Core AUST L 520793) suppresses Signal 2 activation through P2X7 receptor Mg²⁺ competition; curcumin-piperine (CurcuNova AUST L 520796) addresses Signal 1 NF-κB priming and Signal 2 ASC speck assembly inhibition — making their combination the most mechanistically complete NLRP3 nutritional intervention in the Zenutri range.

What role do NK cells play in immune defence, and how does selenium support them?

NK cells provide innate immune cytotoxic surveillance for MHC class I-downregulated targets (virally infected cells, tumour cells) through NKG2D and DNAM-1 stress ligand recognition, delivering cytotoxicity via perforin pore formation and granzyme serine protease apoptotic cascade. Selenium supports NK cell function through selenoprotein P in the NK developmental microenvironment and GPx selenoprotein protection of cytotoxic granule contents during degranulation. Selenomethionine 100mcg in Immunaxis (AUST L 521494) provides the most bioavailable oral selenium form for selenoprotein synthesis, confirmed by Toulis 2010; zinc glycinate 20mg supports IL-2/IL-15 NK expansion signalling simultaneously.

What are specialised pro-resolving mediators and why does resolution matter?

SPMs — lipoxins (from arachidonic acid), resolvins (E-series from EPA, D-series from DHA), protectins (from DHA) — actively programme inflammatory resolution through specific GPCR signalling (ALX/FPR2 for LXA4, ChemR23 for RvE1, GPR18 for RvD2) that promotes neutrophil apoptosis, macrophage efferocytosis of debris, and tissue homeostasis restoration. Resolution is not passive dissipation but an active, genetically programmed response that requires availability of DHA/EPA precursors and lipoxygenase enzyme function. An immune system unable to efficiently resolve responses — from insufficient omega-3 substrate, selenium 15-LOX co-factor insufficiency, or Vitamin C collagen-remodelling inadequacy — accumulates the chronic unresolved inflammation that drives inflammageing independently of any acute pathogen challenge.

How does gut health affect immune function?

Approximately 70% of the body's immune cells reside in GALT. M cells overlying Peyer's patches sample luminal antigens for dendritic cell presentation, driving IgA class switching in germinal centres (Vitamin A retinoic acid co-factor — Immunaxis). Butyrate from commensal bacterial fibre fermentation inhibits HDAC and promotes FOXP3 Treg differentiation in the lamina propria — calibrating immune tolerance. D3 VDR directly drives FOXP3 expression in intestinal Tregs (Osteo+Core). Zinc tight junction maintenance prevents LPS paracellular translocation that constitutes the chronic NLRP3 Signal 1 of gut permeability dysbiosis — making Immunaxis zinc glycinate the most structurally foundational gut-immune intervention in the Zenutri range.

What is the difference between immune activation and immune resolution and why do both matter?

Immune activation — the inflammatory response to pathogen detection — is the dimension most supplement marketing addresses. Immune resolution — the active programme that terminates that response and restores tissue homeostasis through SPMs — is equally essential and nutritionally dependent. An immune system with robust activation but impaired resolution produces the chronic low-grade inflammatory background that defines inflammageing: elevated CRP, IL-6, and TNF-α without acute infection, driven by unresolved low-grade exposures whose SPM-mediated resolution is substrate-limited by DHA/EPA insufficiency, selenium lipoxygenase co-factor insufficiency, or Vitamin C collagen-remodelling inadequacy. Addressing both phases — activation support through zinc, selenium, and Vitamin C; and resolution support through the antioxidant network that protects EPA/DHA SPM precursors — is the defining characteristic of a complete immune-nutrient synergy protocol.

How does the Zenutri Immune & Antioxidant Nutrient Bundle address multiple immune mechanisms?

The Immune & Antioxidant Nutrient Bundle (Immunaxis AUST L 521494 + CurcuNova AUST L 520796 + C E B Optima AUST L 521487, $57.50) addresses at minimum six distinct immune mechanisms: zinc-thymulin T cell maturation and NK cell expansion; selenium GPx4 ferroptosis protection and NK degranulation; Vitamin A IgA class switching and Peyer's patch mucosal immunity; curcumin-BioPerine NF-κB NLRP3 Signal 1 suppression and ASC speck inhibition; Vitamin C SPM precursor antioxidant protection and collagen resolution remodelling; and mixed tocopherol lipid-phase membrane protection preserving DHA/EPA as resolvin/protectin substrates. This multi-mechanism coverage through a single $57.50 bundle reflects the nutrient synergy model that coordinates complementary molecular pathways rather than stacking high doses of a single ingredient.